Individual patient risk assessment and cost–benefit analysis of patiromer in AMBER – Authors' reply

The Lancet(2020)

引用 0|浏览13
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要